Olympus announced today that it launched Olympus Innovation Ventures Fund II, deploying $150 million for medtech investments.

Philips (NYSE: PHG) announced that it agreed to acquire SpectraWave, a developer of Enhanced Vascular Imaging (EVI) for ...

Nephrodite CEO Nikhil Shah described the first-of-its-kind continuous dialysis implant system as a "healthy alternative" to ...

Subsense announced that it added $10 million in new capital to support its nanoparticle-based brain-computer interface (BCI) platform.

Datasea (Nasdaq:DTSS) announced progress on R&D efforts related to its brain-computer interface (BCI) technologies.

Salmon retired from Medtronic in September after a more than 20-year tenure at the medtech giant. Most recently, Salmon ...

ProVerum and Zenflow both this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia ...

Johnson & Johnson MedTech will be one of several companies set to benefit from a new CMS decision related to pulsed field ...

Neurovalens announced that it received FDA de novo approval for Modius Lean, its non-invasive neurotechnology for weight ...

Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive ...

GE HealthCare (Nasdaq: GEHC) has sent affected customers a letter recommending updated instructions for certain anesthesia ...

Brain-computer interface (BCI) company Science Corp. announced that it appointed Darius Shahida as its new chief strategy ...